Definition and epidemiology
Heterochromia refers to a visible difference in iris pigmentation. It is classified into three main types:
- Complete heterochromia (heterochromia iridum): each iris is a completely different color
- Sectoral heterochromia: a segment of one iris differs in color from the remainder of that iris
- Central heterochromia: the inner ring of the iris differs in color from the outer ring
The condition is also classified by timing:
- Congenital heterochromia: present from birth, usually benign
- Acquired heterochromia: develops later in life, often associated with pathology
Congenital heterochromia affects approximately 1 in 1,000 individuals, with no significant sex or ethnic predilection. Acquired heterochromia is less common and varies in incidence depending on the underlying etiology. Most cases presenting in childhood without other ocular findings are benign and require no intervention.
- Heterochromia in a child with miosis and ptosis WITHOUT a history of birth trauma requires a neuroblastoma workup to rule out a sympathetic chain mass
- Heterochromia developing after age 2 rules out Horner syndrome as the cause (pigmentation already complete)
- Waardenburg syndrome: sensorineural hearing loss, white forelock, dystopia canthorum, and heterochromia or brilliant blue eyes
- Fuchs heterochromic iridocyclitis presents with lighter iris, fine keratic precipitates, cataract, and does not respond to steroids
- Nevus of Ota (oculodermal melanocytosis) increases risk of uveal melanoma; requires lifelong surveillance
- Prostaglandin analogs (latanoprost, bimatoprost) cause permanent iris darkening, most pronounced in hazel or green eyes
- Benign congenital heterochromia requires no treatment or follow-up if examination is otherwise normal
- Acute-onset Horner syndrome in an adult warrants urgent imaging for carotid dissection or Pancoast tumor
Etiology and risk factors
Congenital causes
Benign congenital heterochromia is the most common form, representing a developmental variation in melanocyte distribution with no associated systemic or ocular disease. It may be sporadic or rarely inherited in an autosomal dominant pattern.
Congenital Horner syndrome results from disruption of the sympathetic pathway before age 2, leading to iris hypopigmentation on the affected side. Causes include birth trauma, neuroblastoma, and chest or neck masses.
Waardenburg syndrome is an autosomal dominant disorder characterized by sensorineural hearing loss, white forelock, dystopia canthorum, and often complete heterochromia or brilliant blue irides bilaterally.
Piebaldism features patchy skin depigmentation and may present with sectoral iris hypopigmentation.
Sturge-Weber syndrome can cause diffuse iris heterochromia due to increased iris vascularity on the side of the facial port-wine stain.
Acquired causes
Acquired Horner syndrome in adults or older children causes lighter iris color on the affected side due to sympathetic denervation. Etiologies include carotid dissection, Pancoast tumor, brainstem stroke, and iatrogenic injury.
Ocular trauma may cause either hyperpigmentation from iris damage and pigment liberation or hypopigmentation from iris atrophy.
Chronic anterior uveitis (especially Fuchs heterochromic iridocyclitis) causes iris atrophy and lighter color on the affected side, often with fine keratic precipitates and cataract.
Iridocorneal endothelial (ICE) syndrome leads to iris atrophy and color changes, typically in middle-aged women, with associated corneal edema and glaucoma.
Ocular melanosis and oculodermal melanocytosis (nevus of Ota) cause darker iris color on the affected side and carry an increased risk of uveal melanoma and glaucoma.
Iris melanoma may present as progressive darkening of one iris or a sector.
Siderosis bulbi from retained intraocular iron foreign body causes rust-colored iris discoloration.
Medications including prostaglandin analogs (latanoprost, bimatoprost) used for glaucoma cause increased iris pigmentation, particularly in hazel or green irides.
Pathophysiology
Iris color is determined by the concentration and distribution of melanin within iris melanocytes (which are present in equal numbers across all eye colors). Brown irides contain high melanin density in both the anterior border layer and stroma, while blue irides have minimal anterior pigment and rely on stromal Rayleigh scattering of light.
In congenital heterochromia, genetic or developmental factors lead to asymmetric melanocyte activation or melanin production, but melanocyte numbers remain normal. The difference is established by age 1-2 years as iris pigmentation matures.
In Horner syndrome, loss of sympathetic innervation before age 2 prevents normal iris pigmentation. The affected iris remains lighter because melanin synthesis in iris melanocytes is partially sympathetically mediated during development. Acquired Horner syndrome after age 2 does not cause heterochromia because melanin deposition is already complete.
Inflammatory and traumatic heterochromia results from iris stromal atrophy, melanocyte loss, or pigment liberation. Chronic inflammation causes melanocyte death and stromal thinning, lightening the iris. Conversely, acute trauma may deposit pigment on the iris surface or trabecular meshwork.
Neoplastic heterochromia (melanoma, melanocytoma, melanosis) reflects increased melanocyte number or activity, darkening the affected iris.
Prostaglandin analogs upregulate tyrosinase activity and melanin production in existing melanocytes, causing gradual darkening over months.
Clinical features
Benign congenital heterochromia
Patients present with visible iris color difference noted by family members, typically recognized in early childhood. There are no visual symptoms, pain, photophobia, or associated findings. Examination reveals clear media, normal pupils, no anisocoria, and no other ocular abnormalities. Visual acuity is normal.
Congenital Horner syndrome
Presents with the classic triad plus heterochromia:
- Miosis: smaller pupil on affected side
- Ptosis: mild upper lid droop (1-2 mm)
- Anhidrosis: absent or reduced facial sweating (if lesion is proximal)
- Iris hypopigmentation: lighter iris on affected side
Birth history may reveal shoulder dystocia, forceps delivery, or cervical mass.
Acquired Horner syndrome
In adults, miosis, ptosis, and anhidrosis occur without iris color change. However, acute onset should prompt urgent evaluation for carotid dissection (especially with neck or facial pain) or apical lung mass.
Fuchs heterochromic iridocyclitis
Typically presents in young to middle-aged adults with:
- Unilateral gradual vision loss
- Minimal to absent pain or redness despite chronic inflammation
- Lighter iris color on affected side
- Fine stellate keratic precipitates diffusely distributed
- Mild anterior chamber flare without posterior synechiae
- Cataract formation common
- Elevated intraocular pressure in some cases
Waardenburg syndrome
Systemic features include:
- Sensorineural hearing loss (bilateral, congenital)
- White forelock (poliosis)
- Premature graying
- Broad nasal root and dystopia canthorum (laterally displaced inner canthi)
- Heterochromia or brilliant blue irides
Nevus of Ota
Presents with unilateral periorbital bluish-gray hyperpigmentation involving skin in the distribution of the first and second trigeminal divisions, ipsilateral scleral melanosis (bluish sclera), and darker iris on the same side. Most common in Asian and African populations.
Diagnosis
Diagnosis is primarily clinical, based on careful history and ophthalmologic examination.
History
- Onset: congenital (noted in infancy) versus acquired (new in childhood or adulthood)
- Associated symptoms: vision changes, pain, photophobia, floaters, trauma, medication use
- Birth history: trauma, difficult delivery (for congenital Horner syndrome)
- Family history: heterochromia, deafness, pigmentary disorders
- Systemic symptoms: hearing loss, headache, neck pain, neurologic deficits
Examination
Slit-lamp biomicroscopy is essential:
- Document which eye is lighter or darker
- Assess for iris atrophy, transillumination defects, or sectoral changes
- Examine for keratic precipitates, anterior chamber cells, synechiae
- Evaluate lens for cataract
- Check intraocular pressure
Pupil examination:
- Assess for anisocoria
- Perform pharmacologic testing if Horner syndrome suspected (apraclonidine or cocaine drops)
- In Horner syndrome, the affected pupil dilates poorly in darkness
Gonioscopy may reveal angle abnormalities in ICE syndrome or pigment deposition in siderosis.
Dilated fundus examination to rule out posterior segment pathology, retinal detachment, or choroidal mass.
Ancillary testing
Imaging is indicated in specific scenarios:
- Congenital Horner syndrome WITHOUT documented birth trauma: MRI of brain, neck, and chest to exclude neuroblastoma or structural lesions
- Congenital Horner syndrome WITH clear birth trauma history: imaging generally not indicated
- Acquired Horner syndrome: MRI/MRA of brain and neck (carotid dissection), CT chest (Pancoast tumor)
- Suspected uveal melanoma: ocular ultrasound
Urine catecholamines (vanillylmandelic acid, homovanillic acid) if neuroblastoma suspected in idiopathic congenital Horner syndrome.
Audiometry if Waardenburg syndrome suspected.
No laboratory workup is needed for isolated benign congenital heterochromia in an otherwise healthy child.
Differential diagnosis
The key differential lies in distinguishing benign congenital heterochromia from pathologic acquired forms.
| Condition | Key distinguishing features |
|---|---|
| Benign congenital heterochromia | Present from birth, no other ocular or systemic findings, normal vision |
| Congenital Horner syndrome | Miosis, ptosis, anhidrosis, lighter iris on affected side, history of birth trauma or neck mass |
| Waardenburg syndrome | Sensorineural hearing loss, white forelock, dystopia canthorum, family history |
| Fuchs heterochromic iridocyclitis | Unilateral, acquired in young adult, fine keratic precipitates, cataract, minimal inflammation |
| Horner syndrome (acquired) | Acute onset miosis and ptosis in adult, no iris color change, consider dissection or malignancy |
| ICE syndrome | Middle-aged woman, progressive iris atrophy, corneal edema, glaucoma |
| Ocular melanosis/nevus of Ota | Darker iris, periorbital skin and scleral pigmentation, increased melanoma risk |
| Iris melanoma | Progressive unilateral iris darkening or mass, elevated lesion on examination |
| Siderosis bulbi | History of metallic foreign body, rust-colored deposits, ERG abnormalities |
| Prostaglandin analog use | Gradual darkening over months, history of glaucoma treatment, bilateral possible if both eyes treated |
Other considerations include iris heterotopy (ectopic iris tissue), iris coloboma (which may appear as sectoral color difference), and aniridia (absence of iris, usually bilateral).
Management
Benign congenital heterochromia
No treatment is required. Reassure the patient and family. Routine ophthalmologic follow-up is not necessary if the examination is otherwise normal. Patients may use colored contact lenses for cosmetic reasons if desired, but this is not medically indicated.
Congenital Horner syndrome
Management focuses on identifying and treating the underlying cause:
- If documented birth trauma is present: reassurance and observation; imaging is generally not required
- If no clear birth trauma or unexplained presentation: urgent imaging (MRI brain, neck, chest) to rule out neuroblastoma or structural lesions, and urine catecholamine screening
- Referral to pediatric oncology if mass identified
- No treatment for the heterochromia itself
- Long-term ophthalmologic follow-up not required if no ocular complications
Acquired Horner syndrome
- Emergent imaging for carotid dissection or stroke if acute onset
- CT chest for Pancoast tumor in smokers or those with shoulder/arm pain
- Treatment directed at underlying cause
- Heterochromia does not occur if onset is after age 2
Fuchs heterochromic iridocyclitis
- Observation in mild cases, as inflammation is typically low-grade
- Topical corticosteroids are generally ineffective and not routinely used
- Cataract surgery when visually significant; outcomes are generally good but increased risk of intraoperative bleeding
- Glaucoma management with medications or surgery if intraocular pressure is elevated
- Screen for rubella virus in atypical cases (some evidence suggests association)
Waardenburg syndrome
- Audiologic evaluation and hearing aids if sensorineural hearing loss present
- Genetic counseling (autosomal dominant inheritance)
- No ocular treatment needed
Ocular melanosis and nevus of Ota
- Regular surveillance for uveal melanoma (annual dilated fundus examination)
- Glaucoma screening (increased risk of secondary glaucoma)
- Cosmetic camouflage or laser treatment for skin pigmentation if desired
- No treatment prevents malignant transformation
Iris melanoma
- Referral to ocular oncology
- Treatment options include plaque radiotherapy, local resection, or enucleation depending on size and location
- Prognosis depends on tumor size and cell type
Prostaglandin analog-induced heterochromia
- Inform patients before initiating therapy that iris darkening may occur
- Darkening is permanent but harmless
- Switch to alternative glaucoma medication if cosmetically unacceptable to patient
Complications and prognosis
Benign congenital heterochromia
Prognosis is excellent. The condition is permanent but purely cosmetic. There is no increased risk of ocular disease, vision loss, or systemic complications. No long-term ophthalmologic follow-up is needed.
Congenital Horner syndrome
Prognosis depends on the underlying etiology:
- If caused by benign birth trauma with no structural lesion, prognosis is excellent
- Neuroblastoma carries variable prognosis depending on stage and age at diagnosis; early detection improves outcomes
- The heterochromia, miosis, and ptosis are permanent and typically do not require treatment
- Rarely, significant ptosis may require surgical correction if amblyopia risk exists
Fuchs heterochromic iridocyclitis
Complications include:
- Cataract formation (very common, often requiring surgery)
- Glaucoma (10-15% of cases, may be difficult to control)
- Vitreous hemorrhage (rare)
Visual prognosis is generally good with appropriate management. The condition typically does not respond to corticosteroids and tends to burn out over time.
Ocular melanosis
The primary concern is malignant transformation:
- Uveal melanoma develops in approximately 1 in 400 patients with oculodermal melanocytosis over their lifetime (much higher than general population risk)
- Glaucoma occurs in up to 10% of patients
- Regular surveillance is essential; prognosis for detected melanoma depends on size and spread
Iris melanoma
Prognosis depends on tumor characteristics:
- Small tumors treated with local therapy have 5-year survival exceeding 90%
- Larger tumors or those requiring enucleation have lower survival rates
- Risk of metastasis correlates with tumor size and cell type (epithelioid worse than spindle)
ICE syndrome
Progressive condition with poor prognosis for the affected eye:
- Glaucoma is often refractory to medical management and may require surgery
- Corneal edema may necessitate penetrating keratoplasty
- Vision loss may be significant despite treatment
Overall, the prognosis for heterochromia depends entirely on the underlying cause. Isolated benign congenital heterochromia has no impact on health or vision, while acquired forms signal pathology that may carry significant morbidity.
Practice questions
1. A 3-year-old boy is brought to the pediatrician for evaluation of different colored eyes, which his parents noticed at 6 months of age. His right iris is brown and his left iris is blue. He was born by difficult forceps delivery with shoulder dystocia. Examination reveals a 1 mm ptosis of the left upper eyelid and a smaller left pupil that dilates poorly in darkness. Visual acuity is normal for age. Which of the following is the most appropriate next step in management?
2. A 32-year-old woman presents with gradual blurring of vision in her left eye over 2 years. She denies pain or redness. Examination shows visual acuity of 20/50 in the left eye and 20/20 in the right. Her left iris is noticeably lighter than the right. Slit-lamp examination reveals fine, stellate keratic precipitates scattered diffusely on the left corneal endothelium, mild anterior chamber flare, and a posterior subcapsular cataract. Intraocular pressure is 18 mmHg in both eyes. Which of the following is the most likely diagnosis?
3. A 6-month-old girl is brought in for evaluation of hearing loss and unusual facial features. Her eyes are different colors: the right iris is brown and the left is bright blue. She has a white forelock and the inner corners of her eyes appear widely spaced. Audiometry confirms bilateral profound sensorineural hearing loss. Her 35-year-old mother has similar facial features and wears hearing aids. What is the most likely mode of inheritance?
Frequently asked questions
What causes heterochromia?
Heterochromia results from differences in iris melanin concentration. Most cases are benign and congenital, due to developmental variation in melanocyte activity. Acquired causes include Horner syndrome (sympathetic nerve damage), trauma, chronic inflammation like Fuchs heterochromic iridocyclitis, ocular melanosis, iris tumors, intraocular foreign bodies, and prostaglandin analog eye drops used for glaucoma. Congenital heterochromia is also associated with Waardenburg syndrome, Sturge-Weber syndrome, and piebaldism.
What are the first symptoms of heterochromia?
Benign congenital heterochromia typically has no symptoms other than the visible iris color difference, usually noticed by parents in early childhood. The child has normal vision and no discomfort. Acquired heterochromia may present with associated symptoms depending on the cause: vision changes and floaters in uveitis, eye pain after trauma, or neurologic symptoms like ptosis and miosis in Horner syndrome. If heterochromia develops suddenly in adulthood, urgent medical evaluation is needed.
How is heterochromia diagnosed?
Diagnosis is made by clinical examination. A detailed history establishes whether the condition is congenital or acquired. Slit-lamp examination assesses iris structure, looks for inflammation or atrophy, and checks intraocular pressure. Pupil testing identifies Horner syndrome. If congenital Horner syndrome is suspected without clear birth trauma, imaging of the brain, neck, and chest is performed to rule out neuroblastoma. Acquired cases may require MRI for carotid dissection or chest CT for lung tumors. Benign congenital heterochromia needs no testing beyond examination.
Is heterochromia curable?
Benign congenital heterochromia is permanent and requires no treatment. Acquired heterochromia depends on the underlying cause. The color difference itself cannot be reversed, even if the cause is treated. Prostaglandin-induced darkening is permanent. Some patients choose colored contact lenses for cosmetic reasons. Treatment focuses on managing underlying conditions (e.g., glaucoma in Fuchs heterochromic iridocyclitis, tumor removal in iris melanoma) rather than correcting the color difference. The heterochromia in Horner syndrome is lifelong regardless of treatment.
Heterochromia vs anisocoria — what is the difference?
Heterochromia refers to difference in iris color between the two eyes or within one eye. Anisocoria refers to unequal pupil sizes. The conditions can coexist, particularly in Horner syndrome, where the affected side has both a lighter iris (heterochromia) and a smaller pupil (anisocoria with miosis). However, heterochromia without anisocoria is common in benign congenital cases and Fuchs heterochromic iridocyclitis. Conversely, anisocoria without heterochromia occurs in acquired Horner syndrome in adults and many other pupillary disorders.
Key drugs
Related conditions and differentials
Sources and further reading
StatPearls (NCBI Bookshelf)MedlinePlusWHO ICD-10: H21.24
Educational content for medical students, prepared by the WhiteCoat Pro editorial team with AI assistance; every page is reviewed by a second AI model for factual errors. It is not medical advice and does not replace the product label, local guidelines or a clinician.